(`◔ ω ◔´) try 1ClickPost.com paste text to share free

FDA Approvals in Breast Cancer and Hodgkin Lymphoma, 2017 SGO Highlights, and More

Say and pronounce FDA Approvals In on SuperTTS.com Make Your Own Text-To-Speech Words Instantly

  Info

Description

Brielle Urciuoli reports on FDA approvals in breast cancer and Hodkgin lymphoma, impressive long-term findings in chronic myelogenous leukemia, highlights with rucaparib from the 2017 SGO Annual Meeting, exciting potential with a triple-negative breast cancer treatment, and a partial clinical hold placed on selinexor trials.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
Old Cartoons on DVD. Visit and Bookmark: Cool90s.com!

Related

  FDA Approvals in Breast Cancer and NSCLC, NDA Accepted in HCC, and More   Full FDA Approvals in Breast Cancer and Lung Cancer, Priority Reviews in ALL, and More   FDA Approvals in Breast Cancer and Melanoma, Disappointing Results in HNSCC, and More   FDA Approvals in Hematologic Malignancies, sBLA Accepted in Multiple Myeloma, and More   Rare Form Of Cancer Linked To Breast Implants   FDA Approval in Lung Cancer, Priority Reviews in HCC and NHL, and an ODAC Recommendation   FDA Approvals in ALL and Breast Cancer, Priority Reviews in CML and Follicular Lymphoma, and More   FDA Approvals in MSI-High Cancers, Priority Reviews in Gastric Cancer and FL, and More   FDA Approvals in GVHD, CRC, and AML, a Priority Review in MCL, and More   Dr. Straus on FDA Approval of Pembrolizumab in Hodgkin Lymphoma   FDA Announces Link To Cancer & Breast Implants   FDA Approvals in ALL, Ovarian Cancer, Priority Review in CTCL, and sNDA Submitted in RCC   FDA Approvals in NSCLC, Bladder Cancer, and Breast Cancer, and Death in CAR T-cell Therapy Trial   FDA Approval in Bladder Cancer, Breakthrough Therapy Designation in DLBCL, and More   FDA Approvals in HCC and Gastric Cancer, ODAC Panel Splits on Adjuvant RCC Treatment, and More   Breast Implants Can Cause Rare Cancer, FDA Says   Targeting tumours: Challenges of antibody-drug conjugates   FDA Approvals in Follicular Lymphoma and Prostate Cancer, Biosimilar Is Granted Approval, and More   FDA Approval in Lung Cancer, Promising Findings in Hodgkin Lymphoma, and More   Clinical Experience: CDK4/6 Inhibitors in Breast Cancer   FDA Says Breast Implants Have Possible Link To Rare Form Of Cancer | TODAY   FDA Approvals in Ovarian Cancer and Merkel Cell Carcinoma   FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and a Breakthrough Designation in NSCLC   FDA Approvals in Bladder Cancer, NSCLC, AML, HCC, and Breakthrough Designation in NSCLC   FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights   Dr. Straus on Ongoing Clinical Trials in Hodgkin Lymphoma   Review on 2016 FDA Approvals, Halt on AML Trials, and More   Dr. Nastoupil on Triplet of TGR1202, Ublituximab, and Ibrutinib in CLL   Breast implants are linked to rare cancer deaths   FDA Approvals in CRC, Blood Cancer Detection Diagnostic, and Alopecia, and More   FDA Approvals in CRC, Blood Diagnostic, and Alopecia, and More   FDA FDA: Breast implants can cause rare cancer   Tennessee Woman Gives Birth to Quadruplets While Battling Cancer   FDA Approvals for Daratumumab and Osimertinib, Regulatory Advances in RCC and CLL, and More   FDA Approves MM-398, T-VEC, and Trabectedin, New Pembrolizumab Data, and More   Hodgkin's lymphoma: What you need to know - Mayo Clinic   Alix Beaupierre on Patient Education for CAR T-Cell Therapy Clinical Trials   Dr. Neelapu on Axi-Cel in the ZUMA-1 Trial for Refractory Aggressive Non-Hodgkin Lymphoma   GMO Soy and Breast Cancer   Breast Implants Can Cause Rare Cancer: FDA   Does Aspartame Cause Cancer?   FDA Approval and 2 Priority Reviews in Bladder Cancer, and ASCO's Cancer Advance of the Year   FDA Approval in MZL, Delay in Immunotherapy Combos in NSCLC, and 2017 GI Symposium Highlights   Rare cancer: Breast implants linked to nine deaths from Anaplastic Large Cell Lymphoma - TomoNews   Key Considerations for Treating Recurrent Ovarian Cancer   Pregnant mother diagnosed with cancer   Sandra Allen-Bard on Advocating for Patients with Leukemia and Lymphoma   FDA Approves Use of Breast Cancer Treatment Nerlynx   FDA Approval in Breast Cancer, Breakthrough Designations in AML and Bladder Cancer, and More   FDA Acts Against Companies Selling Illegal Cancer Treatments and Clearance on Scalp Cooling System   Dr. Flinn on Long-Term Follow-up of BRIGHT Study in MCL and iNHL   Maryland governor announces cancer diagnosis   Benefits of Turmeric Curcumin for Inflammatory Orbital Pseudotumor   Dr. Leonard on Treatment Options for Patients With Indolent B-Cell NHL   Pfizer's Experimental Breast Cancer Drug Succeeds In Mid Stage Trial - Stuart Varney   SECOND OPINION | Non-Hodgkin's Lymphoma | PBS   Cancer Advance of the Year, FDA Approval for CINV, Breakthrough Designation in TNBC, And More   Novartis Metastatic Breast Cancer Treatment   Dr. O'Connor on CD30 Expression in DLBCL   Dr. Andorsky on the MAGNIFY Trial in Follicular Lymphoma   Dr. Andorsky on Next Steps Following MAGNIFY Trial in Follicular Lymphoma   Experimental Therapy Winning Battle Against Lymphoma   Brentuximab Vedotin in Hodgkin Lymphoma   College swimmer comes back from cancer   Caldwell woman gets cancer from breast implants   Breast Implants Increase the Risk of Cancer   Dr. Cheah on Treatment for Nodular Lymphocyte Hodgkin Lymphoma   FDA Approval in ALL, Priority Reviews in CML and Breast Cancer, and More   Breast cancer: Nighttime lighting may increase risk of breast cancer in young women - TomoNews   Three FDA Approvals, NCI Director Resigns, and More   Dr. Schmitt on a Novel Treatment Approach to Hodgkin Lymphoma   Breast Cancer No Barrier to Pregnancy   Raw Broccoli and Bladder Cancer Survival   Research Shows Effective New Class Of Breast Cancer Drugs Well-Tolerated   FDA Approval in Carcinoid Syndrome Diarrhea, Priority Reviews in Bladder Cancer and NSCLC, and More

Popular Today